Hassane M. Zarour, MD
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Treatment of Advanced Melanoma With MK-3475 and Peginterferon (NCT02112032) | Hassane M. Zarour, MD | 2014-07-24 |
| CpG 7909/Montanide ISA 720 With or Without Cyclophosphamide in Combination Either With NY-ESO-1-derived Peptides or the NY-ESO-1 Protein for NY-ESO-1-expressing Tumors (NCT00819806) | Hassane M. Zarour, MD | 2009-01-01 |
Track Hassane M. Zarour, MD automatically
Every clearance here is in the API, with alerts when new ones post.